API Business Opportunity

Zemplar -Drug Insights, 2016 – A DelveInsight Report

Posted on Updated on

DelveInsight, the leading market research and consulting company has added new report Zemplar -Drug Insights, 2016 to its portfolio. With this launch DelveInsight now has 400+ Reports on Drug Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed.

The Drug Insight Reports provides client with details on global Zemplar -Drug Insights, 2016. It comprehensively includes:

  • Marketed details and the Global API Manufacturers details across the globe along with the location
  • Total sales estimation along with sales forecast till 2018
  • Detailed clinical assessment, patent information
  • SWOT analysis

The report on Zemplar -Drug Insights, 2016 will help in evaluating market scenario and harness opportunities for development by identifying the key patent expiry details and exclusivity with respect to Zemplar. In addition to this the detail sales forecast and SWOT analysis will help companies in finding collaborations and licensing partners.

DelveInsight is offering the Report at a price of USD 1000 as a single user license, USD 2000 as a site license and USD 3000 as a Global/Enterprise License.

For more information on API insight Reports, email at info@delveInsight.com

Contact Us:

DelveInsight Business Research

New Delhi-110075, India

+91-11-45689769, +91-9650213330

 About Us:

DelveInsight is a leading Business Consulting and Market Research Firm.  We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

 

Advertisements

DelveInsight’s Indication Active Pharmaceutical Ingredient (API) Reports– 2015

Posted on

DelveInsight expertise over 400+ Indication Active Pharmaceutical Ingredient (API) Reports

Indication-API Insights

DelveInsight, leading Market Research and Business Consulting firm has an expertise in providing business solutions to Pharma and biotech companies. DelveInsight has 400+ Indication API reports on wide range of therapeutic area such as Oncology, Cardiovascular disease, and Autoimmune disorders and Infectious disease.

DelveInsight’s Indication API insight report provides global competitive and therapeutic assessment on marketed drugs, API manufacturers, patent expiration and exclusivity. The report gives clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries. These Reports gives complete information on marketed drugs along with Global API Manufacturers and regulatory filings across Europe, US, India and China. It gives information of global Market therapeutics scenario, regulatory information, marketing status and detail of product profiles for marketed products with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical description. The Report also provides Global drug sales forecast up to 2016.

The Reports give opportunities to generic manufacturers and also helps API industry to track closest competitors and prioritizing new drug intermediates to add to the portfolio when drug goes off patent. The Indication API insight report helps to identify the strategic drivers and market opportunities.

DelveInsight is offering the Report at a price of USD 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License.

For more information on API insight Reports, email at info@delveInsight.com

About us

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Website Link: http://delveinsight.com/

API Manufacturers Across the Globe: Market Intelligence Report

Posted on Updated on

The Active Pharmaceutical Ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. 

DelveInsight API Insights’ focus uncovers the commercial manufacturing status of 1600 Active Pharmaceutical ingredient molecules and above. The Report opens the opportunities for Generic Industries, Drug Companies as well as API Manufacturers to keep them updated on the API front all across the globe.  The data in the report will provide you with the strategic move for long term successful business.

DelveInsight sfsdfsf

DelveInsight is serving thousands of Companies and associated people in decision making in this highly competitive world.

Pharm API

Get the best out of Pharm API. Pharm API guides you at every step of the API buisness leading to successful milestones.

Report Prices

Drug Reports starts from USD 500
Indication Reports starts from USD 1250

API INSIGHTS

The USDMF and EUDMF filings are the only way for API Manufacturers to take out the business in US and Europe countries. The US and EU5 with a strong business in Pharmaceutical Market provides an indication of which API manufacturers have an interest in penetrating the respective market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently followed by Italy and Spain.

Strategic Advantage 

  • Identification of API Manufacturers for US, Europe, India and China.
  • Potential API identification to add into the Company’s product portfolio.
  • Global Coverage of API Business Opportunities
  • Forecasted drug global sales for 2014-2016
  • Modulate production to reflect demand
  • Understand current market and growth dynamics
  • Estimate patent expiry dates for competitor drugs for your interested indication.
  • Analyze the impact of patent expiry and identify drugs that are vulnerable to generic competition.

The reports give deep details on the API and API Manufacturers information across the globe with their patent expiration details and Drug global sales forecasting till 2016. We can also customize these reports on the basis of clients needs. The reports are available on some of the leading market resellers website such as Report Linker/Report Buyer Market Reports Japan, Market Publishers, MarketReserachReports, MarketResearch.com, JSB Market Research, Reportstack and Bharat Book Bureau.

Or you can directly contact us for the Reports by emailing us at info@delveinsight.com